To overcome the issues that affect the traditional method used for the measurement of OPN (ELISA assay), Sharma et al. covalently combined OPN monoclonal antibodies onto the SWCNTs@COOH surface, achieving an NIS to determine OPN for prostate cancer diagnosis [264]. Here, SPP1 is linked to prostate carcinoma.